Biomarkers – News and Features

We spoke with Dr. Michael Gonzales to learn more about the UKB-PPP and its goals, the technical hurdles of large-scale proteomics and how Olink technology is helping to overcome them.

Scientists have revealed how a tiny chemical modification in RNA, known as m6A, plays a critical role in the progression of prostate cancer, including driving some of its most dangerous forms of the disease.

Researchers found marathon running causes a temporary reduction in brain myelin, especially in areas related to motor function and emotional regulation. Using MRI techniques, they identified a 28% decrease in myelin content.

A research team has uncovered abnormal immune cell function mechanisms that may lead to Crohn’s disease. Their discovery provides a better understanding of disease development and could inform the development and design of new therapies.

A study from the University of the Basque Country explores blood-based biomarkers to understand why some cannabis users develop schizophrenia. Using lipidomics, researchers identified specific fatty acid profiles that differentiated users.

Speaking at a recent Technology Networks’ symposium, Dr. Jason Reeves explained how AI is changing the development of antibody–drug conjugates.

Researchers found that levodopa, a medication that increases dopamine levels, could help treat depression with motivational impairments due to high inflammation. The study identified C-reactive protein (CRP) as a predictor for response to levodopa.

A new study suggests there may be an easy way to predict which women are most at risk – low creatinine-to-cystatin C ratios.

Endometriosis affects 1 in 10 women, yet diagnosis takes nearly a decade, leading to prolonged pain, infertility and organ damage. Improved awareness, research and reduced wait times are crucial for earlier detection and better patient outcomes.

The new method can measure 25 important markers in the blood simultaneously, such as cholesterol, in less than 15 minutes using radio waves. This new application could support more patients achieve an early heart disease diagnosis.